Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

DMII

Drugs Made In America Acquisition II Corp

Last Close
10.10
Jul 24 • 10:10 AM ET Dollar change+0.01 Percentage change(0.10%)
Aftermarket Close
10.09
Aftermarket • 4:15 PM ET Dollar change-0.01 Percentage change(-0.10%)
Index
-
Market Cap
643.37M
Enterprise Value
643.47M
Income
8.58M
Sales
0.00M
Book/sh
7.72
Cash/sh
0.01
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
2
IPO
Dec 03, 2025
P/E
75.37
Forward P/E
-
PEG
-
P/S
-
P/B
1.31
P/C
1838.20
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
0.53
Current Ratio
0.53
Debt/Eq
0.00
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
0.13
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
- -
EPS Y/Y TTM
-
Sales Y/Y TTM
-
EPS Q/Q
7666.67%
Sales Q/Q
-
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
22.15%
Insider Trans
0.00%
Inst Own
69.08%
Inst Trans
-
ROA
3.37%
ROE
3.49%
ROIC
1.75%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
0.14%
SMA50
0.30%
SMA200
1.06%
Trades
Shs Outstand
63.70M
Shs Float
49.59M
52W High
10.11 -0.10%
52W Low
9.86 2.43%
Volatility
0.13% 0.11%
ATR (14)
0.01
RSI (14)
57.79
Beta
-
Rel Volume
0.00
Avg Volume
128.02K
Volume
170
Perf Week
0.20%
Perf Month
0.00%
Perf Quarter
0.90%
Perf Half Y
1.30%
Perf YTD
2.02%
Perf Year
-
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
10.09
Price
10.10
Change
0.10%
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in New York, NY.
Chief Executive OfficerMr. Roger Bendelac
CFO & Principal Accounting OfficerMr. Saleem Elmasri CPA